Login / Signup

Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning-do we need 200 mg/kg cyclophosphamide?

Ross PenglaseHelen EnglertKathleen TymmsAndrew CarrDavid MaSam MillikenJohn Moore
Published in: Bone marrow transplantation (2022)
Keyphrases
  • stem cell transplantation
  • high dose
  • low dose
  • multiple sclerosis
  • drug induced
  • bone marrow
  • early onset
  • cell therapy
  • mesenchymal stem cells